高级检索

我国医药制剂出口竞争力研究

Research on exporting competitiveness of pharmaceuticals in China

  • 摘要: 根据我国医药产品出口现状及特点,并以制剂产品作为切入点,从反映外贸规模、外贸质量和贸易进度的3个维度选择了净出口额、出口贡献率、国际市场占有率、显示性比较优势指数、竞争优势指数、Michaely指数和出口优势增长指数等7个指数,构建了制剂出口竞争力评价体系。为了避免由于各指数的角度不同所造成的结果矛盾,本文通过主成分分析方法将指标抽象成2个综合指标,以直观地衡量和比较世界主要制剂进出口国家和地区制剂产品的出口竞争力。实证结果表明,我国的医药制剂出口竞争力在10个世界主要的制剂进出口国家中排名第6。在此基础上,辩证地借鉴制剂产品出口竞争力较强的国家瑞士的发展经验,提出促进我国制剂产品出口长远发展的相应对策。

     

    Abstract: Pharmaceuticals were chosen as the entry point to analyze the status and characteristics of China′s pharmaceutical exports. An export competitiveness evaluation system was comprehensively constructed by selecting the scale, quality and progress of international trade as three dimensions. Net exports, export contribution rate, international market share, display comparative advantage index, competitive advantage index, Michaely index and export advantage growth index as seven indices. In order to avoid the discrepancy caused by the different angles of each index, the indicators were abstracted into two comprehensive ones through principal component analysis, to measure the export competitiveness of the world′s leading countries and regions in pharmaceuticals import and export directly. The result shows that China′s exporting competitiveness of pharmaceuticals ranks the sixth among the 10 major import and export countries in the world. On this basis, dialectical reference is made from Switzerland with strong export competitiveness of pharmaceutical products, in order to promote the long-term development of the export of pharmaceutical products in China.

     

/

返回文章
返回